Haemodynamic Effects of GLP-1 and Glucagon in Healthy Male Volunteers
Status:
Recruiting
Trial end date:
2023-07-01
Target enrollment:
Participant gender:
Summary
The study seeks to explore the cardiovascular effects of co-agonism at two peptide receptors,
GLP-1 and glucagon. Peptides will be intravenously infused, both in isolation, and
combination into healthy male participants. Overall, the aim of the study is to further our
understanding on the role these endogenous substances play (both in isolation and
combination) in haemodynamic regulation.
Phase:
N/A
Details
Lead Sponsor:
Cambridge University Hospitals NHS Foundation Trust